SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ultrafem(UFEM) great potential-new feminine protection

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: KM who wrote (269)5/18/1998 12:37:00 PM
From: Larry Loeb  Read Replies (1) of 272
 
All:

This was filed on Friday (part of new 8-K filing by Ultrafem).:

For Further Information,
Please Contact:
Ultrafem @ 212/921-2070
Dori Reap
Tonya Hinch

FOR IMMEDIATE RELEASE

ULTRAFEM ANNOUNCES DELISTING FROM NASDAQ

NEW YORK, NY, MAY 15, 1998 -- Ultrafem, Inc. announced today that
subsequent to its April 1, 1998 bankruptcy filing, NASDAQ notified the Company
on May 5, 1998 that Ultrafem common stock, which traded under the symbol UFEMQ,
was delisted from the Nasdaq National Market.

In unrelated matters, Richard Cone resigned from the Board of Directors on
April 30, 1998, according to Joy V. Jones, chairperson. The Company also
announced that two additional class action lawsuits have been filed against the
Company, certain of its officers, directors, and former directors. The Company
believes the allegations in these complaints are without merit. These actions
are stayed with respect to Ultrafem as a result of the Chapter 11 filing.

Ultrafem is a women's health care company. The Company's business strategy is
to develop, manufacture and market proprietary products based on its patented
SoftCup(R) technology.

* * * *

-5-


Larry

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext